See All Slides - tctmd.com

Slides

Presentation TCT 2012

Management of the Device Patient for the Non-EP MD

Presenter: Ralph Verdino

October 23, 2012

Presentation TCT 2012

State of the Art

Presenter: Sunil Rao

October 23, 2012

Presentation TCT 2012

Post-MI Alginate to Prevent Remodeling

Presenter: Mitchell Krucoff

October 23, 2012

Presentation TCT 2012

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

Presenter: Markus Schlaich

October 23, 2012

Presentation TCT 2012

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND...

Presenter: Takashi Muramatsu

October 23, 2012

Presentation TCT 2012

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Presenter: Roxana Mehran

October 23, 2012

Presentation TCT 2012

Case Presentation: A Complicated LARIAT Case

Presenter: Randall Lee

October 23, 2012

Advertisement

Slides

Management of the Device Patient for the Non-EP MD

State of the Art

Post-MI Alginate to Prevent Remodeling

Long-term Results from PROTECT AF: Is the Risk-Benefit Ratio Really Uncertain?

Quality-of-Life and Cost-Effectiveness After LAA Closure

TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction

What Will We Learn from the EXCEL Trial that We Do Not Already Know?

TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND...

Modeling the Risk of Stroke and Bleeding in Atrial Fibrillation: What Are the Optimal Risk Scores?

Case Presentation: A Complicated LARIAT Case

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content